Sensex
78,875.78 profit arw 382.24 (0.49%)
Nifty
24,466.25 profit arw 112.70 (0.46%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 13-Apr-2026
Hot Pursuit
13-Apr-2026     11:01

Torrent Pharma gets zero-observation USFDA nod for oncology facility

The inspection was conducted between 6 April and 10 April 2026.

A zero-observation outcome indicates that no Form 483 was issued by the regulator, reflecting compliance with current good manufacturing practices (cGMP) at the facility.

The development is positive for the company's oncology portfolio and supports its regulatory standing in the US market.

Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.

The company's consolidated net profit jumped 27.6% to Rs 642 crore on 17.7% rise in revenue from operations to Rs 3,251 crore in Q3 FY26 over Q3 FY25

Shares of Torrent Pharmaceuticals rose 0.60% to Rs 4,180 on the BSE.

INDIAN INDICES

Sensex

78,875.78 382.24 (0.49%)

Nifty

24,466.25 112.70 (0.46%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

26,160.34 -233.93(-0.89%)